Margarita Calvo *
Director of the Millennium Nucleus for the Study of Pain, MinusPain and academic of the Department of Physiology of Pontificia Universidad Católica de Chile
RESEARCH CARRIED OUT BY CHILEAN SCIENTISTS ACHIEVED IMPORTANT PROGRESS IN THE FIGHT AGAINST GASTRIC CANCER
The study analyzed the behavior of tumor cells and what would be the factors that cause their rapid proliferation and spread throughout the body. With this, the possibility of looking for new therapies to counteract this disease opens up.
A few weeks ago we learned the story of the doctor, an expert in bioethics, Liliana Ortiz, a former academic at the Universidad de Concepción. After dealing with aggressive breast cancer, she decided to receive palliative sedation so that her death would be painless.
WHEN PAIN IS CHRONIC AND DISABLING: RESEARCHERS CREATE MINUSPAIN, THE FIRST SCIENTIFIC CENTER IN THE COUNTRY TO STUDY THIS ISSUE
The Millennium Nucleus seeks to develop neuroscientific research on pain and train specialists in the scientific and clinical area to understand the condition in a comprehensive way.
RESEARCHERS FROM THE FACULTY OF CHEMISTRY AND BIOLOGY WILL BE PART OF TWO OF THE NINE MILLENNIUM NUCLEUS
The research teams led by doctors Rodolfo Madrid and María Pertusa, belonging to the Department of Biology of the Universidad de Santiago, are part of the proposals selected this 2020 by the Millennium Scientific Initiative, a program of the National Research and Development Agency, ANID .
MINUSPAIN: THE TRANSLATIONAL SCIENTIFIC ALLIANCE THAT GATHERS FIVE UNIVERSITIES IN THE COUNTRY TO FACE THE PROBLEM OF CHRONIC PAIN
The Pontificia Universidad Católica de Chile, the Universidad de Concepción, the Universidad de Santiago de Chile, the Universidad Católica del Norte and the Universidad de Chile formed an unpublished scientific association to investigate neuropathic pain mechanisms and find new treatment options. Neuropathic pain generates disabling physical, mental, social and work consequences and is highly prevalent. Current medications are not very effective, so the development of research to understand the mechanisms of pain and generate new therapies is essential.
DIRECTOR OF MINUSPAIN SPEAKS AT AN INTERNATIONAL MEETING ON THE USE OF METFORMIN TO PREVENT NEUROPATHIC PAIN IN ONCOLOGICAL PATIENTS
Dr. Margarita Calvo, director of the Núcleo Milenio MiNuSPain, participated in the first Webinar on «Neuropathic Oncological Pain» organized by the International Committee of Women in Neuromodulation of the Argentine Society of Neuromodulation (SANE)
One in six patients, treated with existing medications, achieves relief between 30% and 50%. A multidisciplinary team seeks to combine preclinical research with clinical research and thus reach the patient more effectively.
Chronic pain is a highly prevalent pathology and, despite this, it is difficult to diagnose and even more complex to treat. The consequences of this are devastating for those who suffer from it and, furthermore, it is a situation little understood by those around them.
MINUSPAIN PROMOTES SCIENTIFIC AND CLINICAL KNOWLEDGE DISSEMINATION PROGRAM FOR PEOPLE WITH FIBROMYALGIA
In collaboration with 8 groups of patients from all over Chile, this Millennium Nucleus began a work aimed at providing updated information on the most recent scientific and clinical advances related to fibromyalgia and chronic pain.